MacroGenics, Inc. (MGNX)

MacroGenics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	66.52	57.22	182.84	100.96	108.88	123.47
Short-Term Investments	87.71	132.7	18.83	128.85	45.46	120.15
Cash & Short-Term Investments	154.23	189.91	201.67	229.81	154.35	243.62
Cash Growth	0.06%	-5.83%	-12.24%	48.89%	-36.64%	-10.61%
Accounts Receivable	10.43	13.37	4.31	10.37	56.22	10.39
Inventory	9.5	7.91	-	1.22	1.45	4.39
Other Current Assets	8.37	8.75	11.51	9.95	10.16	21.17
Total Current Assets	182.52	219.94	217.49	251.34	222.18	279.56
Net Property, Plant & Equipment	33.97	35.52	42.61	45.69	56.91	54.29
Other Long-Term Assets	1.38	1.39	1.56	1.39	1.38	1.4
Total Assets	217.87	256.85	261.66	298.42	280.47	335.25

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.29	4.79	5.01	6.44	4.9	15.5
Accrued Expenses	18.45	22.23	29.33	24.24	29	33.76
Current Portion of Leases	5.21	5.18	4.86	3.78	4.73	4.68
Unearned Revenue	67.99	10.92	16.32	21.65	9.99	20.65
Total Current Liabilities	95.94	43.12	55.53	56.11	48.61	74.58
Long-Term Leases	31.3	31.59	32.6	30.2	30.11	20.79
Other Long-Term Liabilities	69.44	126.56	57.47	59.5	59.74	0.26
Total Long-Term Liabilities	100.74	158.14	90.07	89.7	89.84	21.05
Total Liabilities	196.68	201.26	145.6	145.81	138.46	95.63

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.64	0.63	0.63	0.62	0.62	0.61
Additional Paid-in Capital	1,302	1,299	1,285	1,255	1,235	1,213
Accumulated Other Comprehensive Income	-0.03	0.03	0	-0.01	-0.01	-0.06
Retained Earnings	-1,281	-1,244	-1,170	-1,103	-1,094	-973.94
Shareholders' Equity	21.2	55.59	116.06	152.61	142.01	239.62
Total Liabilities & Equity	217.87	256.85	261.66	298.42	280.47	335.25

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	36.51	36.76	37.46	33.97	34.83	25.47
Net Cash (Debt)	117.72	153.15	164.21	195.83	119.51	218.15
Net Cash Growth	0.90%	-6.73%	-16.15%	63.86%	-45.21%	-10.33%
Net Cash Per Share	1.86	2.42	2.62	3.16	1.95	3.64
Book Value	21.2	55.59	116.06	152.61	142.01	239.62
Book Value Per Share	0.33	0.88	1.85	2.46	2.31	4.00
Tangible Book Value	21.2	55.59	116.06	152.61	142.01	239.62
Tangible Book Value Per Share	0.33	0.88	1.85	2.46	2.31	4.00

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 13, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 4, 2026

Data Sources Report a data error